Fidelity Investments’s Cerenome CNSY Stock Holding History

Fidelity Investments’s Portfolio CNSY Stock Details CNSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$580	–	5555
2023 Q1	$580	Buy	+5	New	+$673	﹤0.01%	4782
2020 Q4	–	Hold	0	–	–	–	4197
2020 Q3	–	Hold	0	–	–	–	3929
2020 Q2	–	Hold	0	–	–	–	4054

Other funds holding CNSY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Fidelity Investments's CNSY Position: Q2 2023 in Review

Fidelity Investments sold out of Cerenome (CNSY) in Q2 2023, closing a stake of 5 shares — an estimated $580 sold.

Fidelity Investments first reported a position in CNSY in Q1 2023 and held it in 1 quarter. The position peaked at $580 in Q1 2023. 6 funds tracked by Wall St. Rank hold CNSY as of Q2 2023.

Fidelity Investments reported no remaining Cerenome position as of Q2 2023 after selling out during the quarter.
Fidelity Investments sold 5 Cerenome shares in Q2 2023, an estimated $580.
Fidelity Investments first reported a position in Cerenome in Q1 2023 and held it in 1 quarter.
Fidelity Investments's Cerenome position peaked at $580 in Q1 2023.
6 funds tracked by Wall St. Rank held Cerenome as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.